申请人:Shionogi & Co., Ltd.
公开号:US04025528A1
公开(公告)日:1977-05-24
Thiazole derivatives represented by the general formula: ##STR1## wherein A is oxygen, sulfur, imino, or NR.sub.3, wherein R.sub.3 is C.sub.1.sub.-5 alkyl, C.sub.2.sub.-5 alkenyl, C.sub.3.sub.-5 alkynyl, C.sub.3.sub.-6 cycloalkyl-C.sub.1.sub.-3 alkyl or C.sub.7.sub.-8 aralkyl; R.sub.1 is hydrogen, C.sub.1.sub.-5 alkyl, C.sub.2.sub.-5 alkenyl, C.sub.3.sub.-5 alkynyl, C.sub.3.sub.-6 cycloalkyl-C.sub.1.sub.-3 alkyl or C.sub.7.sub.- 8 aralkyl; R.sub.2 is hydroxy, C.sub.1.sub.-5 alkoxy or OM, wherein M is alkali metal, or one equivalent of alkaline earth metal, cupric or aluminum cation; n is an integer of 0 or 1; X.sub.1 and X.sub.2 are independently hydrogen or C.sub.1.sub.-5 alkyl; Y.sub.1 and Y.sub.2 are independently hydrogen, halogen, C.sub.1.sub.-5 alkyl, C.sub.1.sub.-5 alkoxy or trifluoromethyl; and the group ##STR2## is linked to one of the meta or para positions of the benzene ring A, n is not 0 when A is imino and --CH.sub.2 --COR.sub.2 does not substitute the thiazole ring when A is imino, being useful as anti-inflammatory, anti-rheumatic, analgesic or anti-lipemia agents.
通式表示的噻唑衍生物:##STR1## 其中A是氧、硫、亚胺或NR.sub.3,其中R.sub.3是C.sub.1.sub.-5烷基、C.sub.2.sub.-5烯基、C.sub.3.sub.-5炔基、C.sub.3.sub.-6环烷基-C.sub.1.sub.-3烷基或C.sub.7.sub.-8芳基烷基;R.sub.1是氢、C.sub.1.sub.-5烷基、C.sub.2.sub.-5烯基、C.sub.3.sub.-5炔基、C.sub.3.sub.-6环烷基-C.sub.1.sub.-3烷基或C.sub.7.sub.-8芳基烷基;R.sub.2是羟基、C.sub.1.sub.-5烷氧基或OM,其中M是碱金属或一当量的碱土金属、铜离子或铝离子;n是0或1的整数;X.sub.1和X.sub.2独立地是氢或C.sub.1.sub.-5烷基;Y.sub.1和Y.sub.2独立地是氢、卤素、C.sub.1.sub.-5烷基、C.sub.1.sub.-5烷氧基或三氟甲基;以及##STR2## 这个基团连接到苯环A的meta或para位置之一,当A是亚胺时,n不是0,当A是亚胺时,--CH.sub.2 --COR.sub.2不替换噻唑环,这些化合物可用作抗炎、抗风湿、止痛或抗脂质血症剂。